Calzolari A, Oliviero I, Deaglio S, et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines[J]. Blood Cells Mol Dis, 2007, 39(1): 82-91. [2]Shah N, Chaudhari K, Dantuluri P, et al. Paclitaxel-loaded PLGA nanparticles surface modified with transferrin and Pluronic((R))-P85, an in vitro cell line and in vivo biodistribution studies on rat model[J]. J Drug Target, 2009, 17(7): 533-542. [3]Schiffelers R M, Molema G, ten-Hagen T L, et al. Ligand-targeted liposomes directed against pathological vasculature [J]. J Liposome Res, 2002, 12(1/2): 129-135. [4]Xiong X B, Huang Y, Lu W L, et al. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo[J]. Pharm Res, 2005, 22(6): 933-939. [5]Oba M, Fukushima S, Kanayama N, et al. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins[J]. Bioconjug Chem, 2007, 18(5): 1415-1423. [6]Teesalu T, Sugahara K N, Kotamraju V R, et al. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration[J]. Proc Natl Acad Sci USA, 2009, 106(38): 16157-16162. [7]赵欣. RGD修饰共载紫杉醇与microRNA-34a脂质体靶向抑制A549肺癌细胞的初步研究[J]. 第三军医大学学报, 2014, 36(11): 1183-1186. [8]Kuai R, Yuan W, Qin Y, et al. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes[J]. Mol Pharm, 2010, 7(5): 1816-1826. [9]Kuai R, Yuan W, Li W, et al. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration[J]. Mol Pharm, 2011, 8(6): 2151-2161. [10]Ying X, Wen H, Lu W L, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals[J]. J Control Release, 2010, 141(2): 183-192. [11]Chang S, Guo J, Sun J, et al. Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells[J]. Ultrason Sonochem, 2013, 20(1): 171-179. [12]Garcia-Garcia E, Andrieux K, Gil S, et al. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? [J]. Int J Pharm, 2005, 298(2): 274-292. [13]Huile G, Shuaiqi P, Zhi Y, et al. A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein[J]. Biomaterials, 2011, 32(33): 8669-8675. [14]Zhang L, Zhang L. Lipid-polymer hybrid nanoparticles: synthesis, characterization and applications[J]. Nano LIFE, 2010, 1(1/2): 163-173. [15]张小文, 吴静. 整合素受体介导共载紫杉醇和姜黄素脂质体的构建及其抗肿瘤研究[J]. 中国生化药物杂志, 2014, 34(1): 62-64. [16]Zhan C, Gu B, Xie C, et al. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect[J]. J Control Release, 2010, 143(1): 136-142. [17]Chen Y, Zhu X, Zhang X, et al. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy[J]. Mol Ther, 2010, 18(9): 1650-1656. [18]赵欣. 载microRNA-34a脂质体靶向治疗肺癌干细胞靶的研究[J]. 中国生化药物杂志, 2014, 34(1): 68-71. [19]Chang J, Jallouli Y, Kroubi M, et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier[J]. Int J Pharm, 2009, 379(2): 285-292. [20]Jiang X, Xin H, Gu J, et al. Solid tumor penetration by integrin-mediated pegylate poly(trimethylene carbonate) nanoparticles loaded with paclitaxel[J]. Biomaterials, 2013, 34(6): 1739-1746.
[2]
杨宪,杨水平,张雪,等.紫杉醇提取工艺的优化试验研究[J].第三军医大学学报,2007,29(19):1886. YANG Xian,YANG Shui-ping,ZHANG Xue,et al.Optimization of taxol extraction from Taxus baccata L.[J].J Third Mil Med Univ,2007,29(12):1886. [2]唐郢,周琦.紫杉醇周疗联合卡铂治疗卵巢癌的临床疗效[J].第三军医大学学报,2007,29(20):2. [3]傅若秋,何凤慈,孟德胜,等.紫杉醇聚乳酸纳米粒的制备[J].第三军医大学学报,2006,28(15):1573. [4]刘鹏辉,廖国清,王红梅,等.紫杉醇和铂剂联合治疗晚期非小细胞肺癌的疗效观察[J].第三军医大学学报,2005,27(18):1847. [5]赵礼金,杨日高,程龙,等.肝内胆管上皮细胞上皮-间叶转化的实验研究[J].第三军医大学学报,2010,32(03):214. Zhao Lijin,Yang Rigao,Cheng Long,et al.Epithelial-mesenchymal transition of intrahepatic biliary epithelial cells[J].J Third Mil Med Univ,2010,32(12):214. [6]张明慧,胡义德,仲晨.含顺铂的4组联合化疗方案治疗晚期非小细胞肺癌的临床疗效比较[J].第三军医大学学报,2009,31(08):744. ZHANG Ming-hui,HU Yi-de,ZHONG Chen.Therapeutic effects of 4 cisplatin-based regimens for advanced non-small cell lung cancer: report of 166 cases[J].J Third Mil Med Univ,2009,31(12):744. [7]李露,陈娟娟,刘先俊.载紫杉醇-阿霉素微泡的制备以及控制释放研究[J].第三军医大学学报,2012,34(05):427. Li Lu,Chen Juanjuan,Liu Xianjun.Preparation and controlled-release characteristics of microbubbles loaded with paclitaxel and doxorubicin[J].J Third Mil Med Univ,2012,34(12):427. [8]熊剑,常慧君,李鹏,等.IBP促进人涎腺腺样囊性癌细胞对紫杉醇耐药[J].第三军医大学学报,2012,34(08):723. Xiong Jian,Chang Huijun,Li Peng,et al.IRF-4 binding protein promotes resistance of human salivary adenoid cystic carcinoma cells to taxol[J].J Third Mil Med Univ,2012,34(12):723. [9]赵欣.RGD修饰共载紫杉醇与microRNA-34a脂质体靶向抑制A549肺癌细胞的初步研究[J].第三军医大学学报,2014,36(11):1183. Zhao Xin.RGD-conjugated paclitaxel and microRNA-34a loaded liposomes target and inhibit A549 cells[J].J Third Mil Med Univ,2014,36(12):1183. [10]董青,杨？波,王琳,等.紫杉醇联合肿瘤坏死因子α诱导腺样囊性癌细胞凋亡的体外研究[J].第三军医大学学报,2006,28(18):1873.
